Matinas Biopharma Holdings, Inc. (MTNB) financial statements (2021 and earlier)

Company profile

Business Address 1545 ROUTE 206 SOUTH
BEDMINSTER, NJ 07921
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5928127433
Cash and cash equivalents1222127433
Short-term investments466     
Restricted cash and investments0000   
Prepaid expense  11   
Other undisclosed current assets32  000
Total current assets:6230138543
Noncurrent Assets
Finance lease, right-of-use asset00
Operating lease, right-of-use asset34
Property, plant and equipment2222000
Long-term investments and receivables   1100
Long-term investments   1100
Intangible assets, net (including goodwill)444444 
Goodwill111111 
Intangible assets, net (excluding goodwill)333333 
Restricted cash and investments000    
Total noncurrent assets:91076551
TOTAL ASSETS:714020141083
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3332111
Accounts payable0101000
Accrued liabilities3211111
Interest and dividends payable  1    
Debt0000000
Deferred revenue and credits000 
Other undisclosed current liabilities0      
Total current liabilities:4332111
Noncurrent Liabilities
Long-term debt and lease obligation34000 0
Finance lease, liability00
Capital lease obligations000 0
Operating lease, liability34
Liabilities, other than long-term debt001111 
Deferred rent credit  1
Deferred tax liabilities, net0111 
Deferred income tax liabilities00
Other undisclosed noncurrent liabilities   1   
Total noncurrent liabilities:4412110
Total liabilities:7744321
Stockholders' equity
Stockholders' equity attributable to parent, including:64331611762
Preferred stock4   6  
Common stock0000000
Additional paid in capital1671137256362916
Accumulated other comprehensive income (loss)0(0)     
Accumulated deficit(108)(84)(66)(51)(35)(23)(14)
Other undisclosed stockholders' equity attributable to parent 4106   
Total stockholders' equity:64331611762
TOTAL LIABILITIES AND EQUITY:714020141083

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Gross profit:0000 0 
Operating expenses(24)(19)(15)(17)(8)(10)(10)
Operating loss:(24)(19)(15)(17)(8)(10)(10)
Nonoperating income (expense)2100(0)0(0)
Investment income, nonoperating11 1110
Debt instrument, convertible, beneficial conversion feature    4  
Other nonoperating income1      
Interest and debt expense(0)(0)(0) (0)(0)(0)
Loss from continuing operations before income taxes:(22)(18)(15)(16)(8)(10)(10)
Income tax expense (benefit)  10  (0)
Net loss:(22)(18)(14)(16)(8)(10)(11)
Other undisclosed net income attributable to parent0101111
Net loss attributable to parent:(22)(17)(14)(15)(8)(9)(10)
Preferred stock dividends and other adjustments (0)(1) (4)  
Other undisclosed net loss available to common stockholders, basic(1)(1) (17)   
Net loss available to common stockholders, diluted:(23)(18)(15)(33)(12)(9)(10)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(22)(18)(14)(16)(8)(10)(11)
Other comprehensive income (loss)0(0)     
Comprehensive loss:(22)(18)(14)(16)(8)(10)(11)
Other undisclosed comprehensive income, net of tax, attributable to parent01     
Comprehensive loss, net of tax, attributable to parent:(22)(17)(14)(16)(8)(10)(11)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: